Press Releases
-
LogiPharma 2024 Highlights: Record Attendance and Groundbreaking Insights
Around 2,000 people attended the 2024 edition of LogiPharma, the annual leading life sciences and supply chain event, making it the largest to date – with 70 percent of exhibition booths already booked for 2025.
May 2, 2024
-
Particle Dynamics Appoints New CFO as it Advances its Strategic Growth Plans
One of the world’s leading oral solid dosage technology companies Particle Dynamics has announced a major new addition to its top team with the appointment of Mike Kanan as Chief Financial Officer
May 2, 2024
-
EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit Presentation will Address Solutions to Real-Time Management of Complex Clinical Data
Munther Baara, VP, Product Strategy & Innovation, EDETEK, Inc. delivered a keynote presentation entitled, “Unlock Clinical Data to Guide Agile Decision Making.” This presentation explores EDETEK's innovative solutions that empower sponsors to seamlessly access, analyze, and act upon clinical data. Mr. Baara’s presentation will highlight the role of the CONFORM™ informatics platform and how this innovative software tool delivers foundational and fundamental solutions in an ever-changing clinical informatics ecosystem.
May 1, 2024
-
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of AI-powered pathology technology, have joined forces to accelerate digital and AI pathology innovations. This collaboration aims to enhance the quality, speed, and efficiency of diagnosing cancer and other diseases, marking a monumental advancement in medical diagnostics.
Apr 30, 2024
-
Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable
May 1, 2024
-
Tower Cold Chain Unveils an Industry-First Container Design
Tower Cold Chain, a leader in passive temperature-controlled containers, has unveiled the KTEvolution 12, setting a new standard in small parcel solutions for pharmaceutical products, thanks to its unique plate design.
Apr 29, 2024
-
CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’
Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025
Apr 29, 2024
-
Ardena's Nanomedicines Facility Marks €20 Million Expansion with first GMP approval
-
SYGNATURE DISCOVERY RECEIVES ECOVADIS AWARD FOR SUSTAINABLE EXCELLENCE
-
Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases
-
Lindus Health Debuts "All-in-One Diagnostics CRO" Solution for Diagnostic Clinical Trials
https://www.prnewswire.com/news-releases/lindus-health-debuts-all-in-one-diagnostics-cro-solution-for-diagnostic-clinical-trials-302126728.html?tc=eml_cleartime Lindus Health Debuts "All-in-One Diagnostics CRO" Solution for Diagnostic Clinical Trials
Apr 24, 2024
-
ChargePoint to expand product range by investing in a dedicated multi-million-pound single-use manufacturing facility
-
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
-
Novel Concepts Medical Announces a Breakthrough Colon Cancer Study
Novel Concepts Medical’s case study shows improvement in a colon cancer patient with metastases in his liver and shrinkage of his tumor size after using our plant-based treatment.
Apr 23, 2024
-
Cyclo Therapeutics, Inc. Announced the Start of its Phase 2b Study for Trappsol Cyclo to Treat Alzheimer's Disease, Aiming to Reduce Amyloid Beta and Tau
Scientists are always looking for ways to develop better medications or other therapies that can help slow down the progression of the disease or improve symptoms. This might involve testing new drugs in the lab or in clinical trials with people who have Alzheimer's.
Apr 21, 2024
-
CordenPharma & GENEPEP Celebrate Strong Collaboration Leveraging Peptide Drug Substance Discovery & Clinical Development Expertise
-
ProPharma Announces Certification as Medidata Rave EDC Accredited Partner
ProPharma, the world’s largest Research Consulting Organization (RCO), and the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, announced that it received accreditation as a CRO partner for Medidata Rave EDC. This milestone marks a significant enhancement in ProPharma's service offering and ability to develop robust, custom electronic data collection systems for clinical research studies.
Apr 17, 2024
-
AES Clean Technology sets new standards for cleanliness and efficiency in cleanrooms with the launch of its CleanLock Module
The CleanLock Module is an airlock solution for cleanroom environments. It offers contamination control, speed, and efficiency in project execution. The module integrates cleanroom finishes, lighting, airflow patterns, and door controls for a highly controlled environment.
Apr 15, 2024
-
PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology
PathAI, a global leader in AI-powered pathology, today announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology (AP) labs accelerate the adoption of AI and digital pathology.
Apr 15, 2024
-
Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint
The two companies have entered into a collaboration agreement to continue the development work of incorporating an environmentally friendly propellant into the formulation of flutiform® (fluticasone propionate/formoterol fumarate) used in a pressurised metered-dose inhaler (pMDI).
Apr 15, 2024